These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 221119)

  • 1. cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.
    Dombernowsky P; Sörenson S; Aisner J; Hansen HH
    Cancer Treat Rep; 1979 Apr; 63(4):543-5. PubMed ID: 221119
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.
    Eagan RT; Frytak S; Creagan ET; Ingle JN; Kvols LK; Coles DT
    Cancer Treat Rep; 1979; 63(9-10):1589-91. PubMed ID: 227597
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
    Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF
    Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of chlorozotocin in advanced bronchogenic carcinoma.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Kvols LK; Ingle JN
    Cancer Treat Rep; 1979; 63(11-12):2105-6. PubMed ID: 230898
    [No Abstract]   [Full Text] [Related]  

  • 5. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
    Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
    Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
    Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinoma.
    Lelli G; Casadio M; Giordani S; Giuliotti C; Canova N; Martoni A; Pannuti F
    Chemioterapia; 1987 Apr; 6(2):134-6. PubMed ID: 3036379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor].
    Tominaga K; Saijo N; Eguchi K; Shinkai T; Shimizu E
    Gan No Rinsho; 1984 Sep; 30(11):1344-50. PubMed ID: 6094880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of small cell bronchogenic carcinoma with VM-26.
    Woods RL; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):2011-3. PubMed ID: 230897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.
    Casper ES; Gralla RJ; Kelsen DP; Cvitkovic E; Golbey RB
    Cancer Treat Rep; 1979; 63(11-12):2107-9. PubMed ID: 575068
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
    Chiuten DF; Carr DT; Dhingra HM; Murphy WK; Spitzer G; Umsawasdi T; Bodey GP; Valdivieso M
    Cancer Treat Rep; 1986 Jun; 70(6):795-6. PubMed ID: 3015403
    [No Abstract]   [Full Text] [Related]  

  • 13. cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.
    Gralla RJ; Cvitkovic E; Golbey RB
    Cancer Treat Rep; 1979; 63(9-10):1585-8. PubMed ID: 498158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary results of a phase-II study with DDP (cis-diaminedichloro-platinum) in the small cell bronchogenic carcinoma].
    Cioccari L; Goldhirsch A; Cavalli F
    Schweiz Med Wochenschr; 1979 Jun; 109(22):845-7. PubMed ID: 223237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
    Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
    Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II).
    Issell BF; Valdivieso M; Bodey GP
    Cancer Treat Rep; 1978 Jul; 62(7):1089-91. PubMed ID: 210943
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.
    Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
    Cancer Treat Rep; 1979; 63(9-10):1621-7. PubMed ID: 291484
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).
    De Jager R; Longeval E; Klastersky J
    Cancer Treat Rep; 1980; 64(12):1341-6. PubMed ID: 6258791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 20. [A phase II study of carboplatin to bronchogenic carcinoma of the lung. Carboplatin Cooperative Study Group for Lung Carcinoma].
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2139-44. PubMed ID: 2840036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.